A practical treatment for superficial telangiectasias of the lower extremities of described that is a modification of sclerotherapy commonly used for the treatment of varicose veins. The key to our technique lies in the use of 32-gauge needles and precise injection of small amounts of sodium tetradecyl sulfate as sclerosant. The cosmetic results of our method are good and our patients are appreciative.
Actinic keratoses are unsightly and may be precancerous. Solitary or localized lesions respond adequately to many forms of treatment. However, widespread multiple actinic keratoses can best be treated with topical 5‐fluorouracil. The exact mode of action is not known, but we can presume it is related to the clearly established effect of this drug upon RNA and DNA synthesis. This treatment is almost ideal, since it usually destroys the keratoses selectively, without significant alteration in normal skin. A 1 or 2 percent solution is made by diluting the 10 ml ampule with propylene glycol. This liquid is applied two times daily to the involved areas for a 2–4 week period. Lesions on the face and neck respond more quickly than those of the hands and arms. A brisk, painful, inflammatory reaction at the site of the keratoses is anticipated and used as an indicator of the end point of treatment. Once treatment is discontinued, the erythema usually subsides in 2 weeks and the skin becomes smooth and free of keratoses. Not all keratoses respond, and untoward reactions such as phototoxicity, irritation of the mucous membranes, contact sensitivity, and alteration of pigmentation can occur. Although resolution of the keratoses persists for years, should they return reapplication is usually effective again.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.